Study type: Human research · Status: Verified against declared source
Comparing the biological activity and composition of Cerebrolysin with other chemical sequence preparations
2024
Study scale: Not reported
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Neurological disorders, ranging from acute forms such as stroke and traumatic brain injury to neurodegenerative diseases like dementia, are the leading cause of disability-adjusted life years (DALYs) worldwide.
Methods
The materials and methods for cell cultivation and cell-based assay to evaluate the neurotrophic activity of the peptide preparations were used and performed as described by Seidl et al.
Scale or participants
Not reported in the reviewed source.
Key findings
Neurological disorders, ranging from acute forms such as stroke and traumatic brain injury to neurodegenerative diseases like dementia, are the leading cause of disability-adjusted life years (DALYs) worldwide.
Limitations and uncertainty
Neurological disorders comprise the leading cause of disability-adjusted life years (DALYs) lost due to death or disability worldwide [1].
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.